nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Oral pain—Epirubicin—bone cancer	0.0688	0.0688	CcSEcCtD
Phentolamine—Oral pain—Doxorubicin—bone cancer	0.0636	0.0636	CcSEcCtD
Phentolamine—Tenderness—Cisplatin—bone cancer	0.0401	0.0401	CcSEcCtD
Phentolamine—Pain—Carboplatin—bone cancer	0.0364	0.0364	CcSEcCtD
Phentolamine—Nasal congestion—Cisplatin—bone cancer	0.0279	0.0279	CcSEcCtD
Phentolamine—Orthostatic hypotension—Cisplatin—bone cancer	0.0232	0.0232	CcSEcCtD
Phentolamine—Injection site pain—Epirubicin—bone cancer	0.022	0.022	CcSEcCtD
Phentolamine—Injection site pain—Doxorubicin—bone cancer	0.0203	0.0203	CcSEcCtD
Phentolamine—Acute coronary syndrome—Cisplatin—bone cancer	0.0193	0.0193	CcSEcCtD
Phentolamine—Myocardial infarction—Cisplatin—bone cancer	0.0192	0.0192	CcSEcCtD
Phentolamine—Bradycardia—Cisplatin—bone cancer	0.0179	0.0179	CcSEcCtD
Phentolamine—Injection site reaction—Epirubicin—bone cancer	0.0178	0.0178	CcSEcCtD
Phentolamine—Injection site reaction—Doxorubicin—bone cancer	0.0165	0.0165	CcSEcCtD
Phentolamine—Flushing—Cisplatin—bone cancer	0.0163	0.0163	CcSEcCtD
Phentolamine—Cardiac disorder—Cisplatin—bone cancer	0.0163	0.0163	CcSEcCtD
Phentolamine—Mediastinal disorder—Cisplatin—bone cancer	0.0158	0.0158	CcSEcCtD
Phentolamine—Arrhythmia—Cisplatin—bone cancer	0.0157	0.0157	CcSEcCtD
Phentolamine—Nervous system disorder—Cisplatin—bone cancer	0.0122	0.0122	CcSEcCtD
Phentolamine—Tachycardia—Cisplatin—bone cancer	0.0122	0.0122	CcSEcCtD
Phentolamine—Abdominal pain upper—Epirubicin—bone cancer	0.0119	0.0119	CcSEcCtD
Phentolamine—Orthostatic hypotension—Epirubicin—bone cancer	0.0119	0.0119	CcSEcCtD
Phentolamine—Hypotension—Cisplatin—bone cancer	0.0117	0.0117	CcSEcCtD
Phentolamine—Paraesthesia—Cisplatin—bone cancer	0.0112	0.0112	CcSEcCtD
Phentolamine—Orthostatic hypotension—Doxorubicin—bone cancer	0.011	0.011	CcSEcCtD
Phentolamine—Abdominal pain upper—Doxorubicin—bone cancer	0.011	0.011	CcSEcCtD
Phentolamine—Angina pectoris—Epirubicin—bone cancer	0.011	0.011	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Cisplatin—bone cancer	0.0108	0.0108	CcSEcCtD
Phentolamine—Pain—Cisplatin—bone cancer	0.0107	0.0107	CcSEcCtD
Phentolamine—Angina pectoris—Doxorubicin—bone cancer	0.0102	0.0102	CcSEcCtD
Phentolamine—Bradycardia—Epirubicin—bone cancer	0.00918	0.00918	CcSEcCtD
Phentolamine—Asthenia—Cisplatin—bone cancer	0.00895	0.00895	CcSEcCtD
Phentolamine—Cardiac disorder—Methotrexate—bone cancer	0.00894	0.00894	CcSEcCtD
Phentolamine—Angiopathy—Methotrexate—bone cancer	0.00874	0.00874	CcSEcCtD
Phentolamine—Mediastinal disorder—Methotrexate—bone cancer	0.00868	0.00868	CcSEcCtD
Phentolamine—Diarrhoea—Cisplatin—bone cancer	0.00853	0.00853	CcSEcCtD
Phentolamine—Bradycardia—Doxorubicin—bone cancer	0.00849	0.00849	CcSEcCtD
Phentolamine—Flushing—Epirubicin—bone cancer	0.00837	0.00837	CcSEcCtD
Phentolamine—Cardiac disorder—Epirubicin—bone cancer	0.00837	0.00837	CcSEcCtD
Phentolamine—Angiopathy—Epirubicin—bone cancer	0.00818	0.00818	CcSEcCtD
Phentolamine—Mediastinal disorder—Epirubicin—bone cancer	0.00812	0.00812	CcSEcCtD
Phentolamine—Arrhythmia—Epirubicin—bone cancer	0.00805	0.00805	CcSEcCtD
Phentolamine—Vomiting—Cisplatin—bone cancer	0.00793	0.00793	CcSEcCtD
Phentolamine—Flushing—Doxorubicin—bone cancer	0.00774	0.00774	CcSEcCtD
Phentolamine—Cardiac disorder—Doxorubicin—bone cancer	0.00774	0.00774	CcSEcCtD
Phentolamine—Angiopathy—Doxorubicin—bone cancer	0.00757	0.00757	CcSEcCtD
Phentolamine—Mediastinal disorder—Doxorubicin—bone cancer	0.00752	0.00752	CcSEcCtD
Phentolamine—Arrhythmia—Doxorubicin—bone cancer	0.00745	0.00745	CcSEcCtD
Phentolamine—Nausea—Cisplatin—bone cancer	0.00741	0.00741	CcSEcCtD
Phentolamine—Chest pain—Methotrexate—bone cancer	0.00714	0.00714	CcSEcCtD
Phentolamine—Hypertension—Epirubicin—bone cancer	0.00678	0.00678	CcSEcCtD
Phentolamine—Nervous system disorder—Methotrexate—bone cancer	0.00671	0.00671	CcSEcCtD
Phentolamine—Chest pain—Epirubicin—bone cancer	0.00668	0.00668	CcSEcCtD
Phentolamine—Hypotension—Methotrexate—bone cancer	0.0064	0.0064	CcSEcCtD
Phentolamine—Nervous system disorder—Epirubicin—bone cancer	0.00628	0.00628	CcSEcCtD
Phentolamine—Hypertension—Doxorubicin—bone cancer	0.00627	0.00627	CcSEcCtD
Phentolamine—Tachycardia—Epirubicin—bone cancer	0.00625	0.00625	CcSEcCtD
Phentolamine—Chest pain—Doxorubicin—bone cancer	0.00618	0.00618	CcSEcCtD
Phentolamine—Paraesthesia—Methotrexate—bone cancer	0.00615	0.00615	CcSEcCtD
Phentolamine—Hypotension—Epirubicin—bone cancer	0.00598	0.00598	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Methotrexate—bone cancer	0.00591	0.00591	CcSEcCtD
Phentolamine—Pain—Methotrexate—bone cancer	0.00585	0.00585	CcSEcCtD
Phentolamine—Nervous system disorder—Doxorubicin—bone cancer	0.00581	0.00581	CcSEcCtD
Phentolamine—Tachycardia—Doxorubicin—bone cancer	0.00578	0.00578	CcSEcCtD
Phentolamine—Paraesthesia—Epirubicin—bone cancer	0.00575	0.00575	CcSEcCtD
Phentolamine—Gastrointestinal pain—Methotrexate—bone cancer	0.0056	0.0056	CcSEcCtD
Phentolamine—Hypotension—Doxorubicin—bone cancer	0.00554	0.00554	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Epirubicin—bone cancer	0.00553	0.00553	CcSEcCtD
Phentolamine—Pain—Epirubicin—bone cancer	0.00548	0.00548	CcSEcCtD
Phentolamine—Abdominal pain—Methotrexate—bone cancer	0.00541	0.00541	CcSEcCtD
Phentolamine—Paraesthesia—Doxorubicin—bone cancer	0.00532	0.00532	CcSEcCtD
Phentolamine—Gastrointestinal pain—Epirubicin—bone cancer	0.00524	0.00524	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00512	0.00512	CcSEcCtD
Phentolamine—Pain—Doxorubicin—bone cancer	0.00507	0.00507	CcSEcCtD
Phentolamine—Abdominal pain—Epirubicin—bone cancer	0.00506	0.00506	CcSEcCtD
Phentolamine—Asthenia—Methotrexate—bone cancer	0.00491	0.00491	CcSEcCtD
Phentolamine—Gastrointestinal pain—Doxorubicin—bone cancer	0.00485	0.00485	CcSEcCtD
Phentolamine—Pruritus—Methotrexate—bone cancer	0.00484	0.00484	CcSEcCtD
Phentolamine—Abdominal pain—Doxorubicin—bone cancer	0.00468	0.00468	CcSEcCtD
Phentolamine—Diarrhoea—Methotrexate—bone cancer	0.00468	0.00468	CcSEcCtD
Phentolamine—Asthenia—Epirubicin—bone cancer	0.0046	0.0046	CcSEcCtD
Phentolamine—Pruritus—Epirubicin—bone cancer	0.00453	0.00453	CcSEcCtD
Phentolamine—Dizziness—Methotrexate—bone cancer	0.00453	0.00453	CcSEcCtD
Phentolamine—Diarrhoea—Epirubicin—bone cancer	0.00438	0.00438	CcSEcCtD
Phentolamine—Vomiting—Methotrexate—bone cancer	0.00435	0.00435	CcSEcCtD
Phentolamine—Headache—Methotrexate—bone cancer	0.00429	0.00429	CcSEcCtD
Phentolamine—Asthenia—Doxorubicin—bone cancer	0.00425	0.00425	CcSEcCtD
Phentolamine—Dizziness—Epirubicin—bone cancer	0.00424	0.00424	CcSEcCtD
Phentolamine—Pruritus—Doxorubicin—bone cancer	0.00419	0.00419	CcSEcCtD
Phentolamine—Vomiting—Epirubicin—bone cancer	0.00407	0.00407	CcSEcCtD
Phentolamine—Nausea—Methotrexate—bone cancer	0.00407	0.00407	CcSEcCtD
Phentolamine—Diarrhoea—Doxorubicin—bone cancer	0.00405	0.00405	CcSEcCtD
Phentolamine—Headache—Epirubicin—bone cancer	0.00401	0.00401	CcSEcCtD
Phentolamine—Dizziness—Doxorubicin—bone cancer	0.00392	0.00392	CcSEcCtD
Phentolamine—Nausea—Epirubicin—bone cancer	0.0038	0.0038	CcSEcCtD
Phentolamine—Vomiting—Doxorubicin—bone cancer	0.00377	0.00377	CcSEcCtD
Phentolamine—Headache—Doxorubicin—bone cancer	0.00371	0.00371	CcSEcCtD
Phentolamine—Nausea—Doxorubicin—bone cancer	0.00352	0.00352	CcSEcCtD
